Research Article

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)

Table 1

Differences and notable characteristics of nonusers, curious users, and active users.

n (%) or mean (SD) 
Demographic and clinical parameters
Nonusers ()MissingCurious users ()MissingActive users ()MissingUnivariate 
value

Men214 (59.3)0 (0)113 (61.4)0 (0)50 (56.8)0 (0)0.760
Age in years62.1 ± 9.5 
63.0 (56.5–68.0)
0 (0)61.8 ± 9.5 
62.0 (56.3–68.0)
0 (0)62.0 ± 9.4 
63.0 (57.0–67.0)
0 (0)0.935
Ethnicity
 Caucasian292 (99.0)66 (18.3)143 (100)41 (22.3)65 (100)23 (6.1)0.706
 Other3 (1.0)0 (0)0 (0)0.382
Employment
 Fulltime/part-time working 99 (34.3)72 (19.9)61 (39.6)30 (16.3)20 (23.8)4 (4.5)0.063
 Retired134 (46.4)70 (45.5)46 (54.8)
 Unemployed/housekeeper38 (13.1)20 (13.0)9 (10.7)
 Incapacitated 18 (6.2)3 (1.9)9 (10.7)
Educational level
 None 0 (0)73 (20.2)1 (0.7)31 (16.8)0 (0)4 (4.5)0.125
 Primary school24 (8.3)9 (5.9)4 (4.8)
 Low127 (44.1)52 (34.0)27 (32.1)
 Intermediate86 (29.9)51 (33.3)30 (35.7)
 High51 (17.7)40 (26.1)23 (27.4)
T2DM duration in years 6.2 ± 4.6 
6.0 (2.0–9.0)
9 (2.5)5.7 ± 4.4  
5.0 (2.0–8.0)
1 (0.5)5.4 ± 4.4 
4.5 (2.0–8.0)
0 (0)0.165
HbA1c in mmol/mol 50.6 ± 9.5 
50.0 (45.0–54.0)
3 (0.8)48.7 ± 7.4 
48.0 (43.0–54.0)
0 (0)47.0 ± 7.0 
46.0 (43.0–50.8)
0 (0)0.001
BMI29.8 ± 4.9 
29.0 (26.5–32.5)
3 (0.8)30.0 ± 4.8 
29.3 (26.9–32.3)
0 (0)29.9 ± 8.0 
28.0 (26.0–32.6)
2 (2.3)0.921

Comorbidities/complications
 Hypertension191 (84.1)134 (37.1)113 (93.4)63 (34.2)51 (92.7)33 (37.5)0.025

Items of Europep: patients who scored 4 (good) to 5 (excellent) 
What is your assessment of the general practitioner over the last 12 months with respect to the following?
 Making it easy for you to tell him or her about your problem345 (93.5)18 (4.7)187 (97.9)17 (8.2)84 (93.3)2 (2.2)0.047

EQ-5D index-score0.9 ± 0.272 (19.9)0.9 ± 0.132 (17.4)0.9 ± 0.24 (4.5)0.030
EQ-VAS 74.7 ± 17.4 
80.0 (60.0–90.0)
74 (20.5)79.3 ± 13.8 
80.0 (73.0–90.0)
35 (19.0)76.9 ± 16.5 
80.0 (0.0–90.0)
5 (5.7)0.032

WHO-5 score indicates suboptimal well-being, screening depression advised36 (12.6)76 (21.1)8 (5.3)33 (17.9)9 (10.8)1 (1.1)0.018
WHO-5 answers advise screening depression 43 (15.5)76 (21.1)6 (4.0)33 (17.9)11 (13.3)1 (1.1)0.002

PAID-5 total score2.8 ± 3.1 
2.0 (0.0–4.5)
76 (21.1)1.8 ± 2.4 
1.0 (0.0–3.0)
32 (17.4)2.2 ± 2.5 
1.0 (0.0–4.0)
1 (1.1)0.016

SDSCA
 Medication in number of days 6.7 ± 1.0 
7.0 (7.0–7.0)
73 (20.2)7.0 ± 0.2 
7.0 (7.0–7.0)
30 (16.3)6.8 ± 0.8 
7.0 (7.0–7.0)
4 (4.5)0.020